RNAI EVIDENCE Trademark

Trademark Overview

On Friday, August 28, 2020, a trademark application was filed for RNAI EVIDENCE with the United States Patent and Trademark Office. The USPTO has given the RNAI EVIDENCE trademark a serial number of 90145170. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, February 22, 2022. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The RNAI EVIDENCE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Maintaining a clinical registry database for patients with genetic mutations; maintaining a registry on the clinical outcomes in patients over time
rnai evidence

General Information

Serial Number90145170
Word MarkRNAI EVIDENCE
Filing DateFriday, August 28, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, February 22, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMaintaining a clinical registry database for patients with genetic mutations; maintaining a registry on the clinical outcomes in patients over time

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, October 2, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, February 22, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, February 22, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 11, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, August 11, 2021FINAL REFUSAL E-MAILED
Wednesday, August 11, 2021FINAL REFUSAL WRITTEN
Tuesday, July 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 12, 2021NON-FINAL ACTION E-MAILED
Tuesday, January 12, 2021NON-FINAL ACTION WRITTEN
Wednesday, December 30, 2020ASSIGNED TO EXAMINER
Friday, October 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 1, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

evidence rnai maintaining registry patients clinical over time outcomes mutations genetic database